Latvija - latviešu - Zāļu valsts aģentūra

biologische heilmittel heel gmbh, germany - cartilago to vadu umbilicalis to embriju viņu kūka viņu pašu, etiķkoku toxicodendron, arnica montana, kartupeļu dulcamara, symphytum officinale, katru dienu, kanādas, sēru, nadidum, coenzymum skābes dl alfa-liponicum, un nātrija diethyloxalaceticum, skābes silicicum - ziede

Latvija - latviešu - Zāļu valsts aģentūra

biologische heilmittel heel gmbh, germany - cartilago to vadu umbilicalis to embriju viņu kūka viņu pašu, etiķkoku toxicodendron, arnica montana, kartupeļu dulcamara, symphytum officinale, katru dienu, kanādas, sēru, nadidum, coenzymum skābes dl alfa-liponicum, un nātrija diethyloxalaceticum - Šķīdums injekcijām

Latvija - latviešu - Zāļu valsts aģentūra

biologische heilmittel heel gmbh, germany - cartilago to vadu umbilicalis to embriju viņu kūka viņu pašu, etiķkoku toxicodendron, arnica montana, kartupeļu dulcamara, katru dienu, kanādas, sēru, skābes silicicum, symphytum officinale, nadidum, coenzymum nātrija diethyloxalaceticum, skābes dl alfa-liponicum - tablete

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

bimeda animal health limited, Īrija - cipermetrīns - šķīdums ārīgai lietošanai - 25 mg/ml - liellopi

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

ceva phylaxia veterinary biologicals co. ltd., ungārija - actinobacillus pleuropneumoniae serotipu 1, celma nt3, actinobacillus pleuropneumoniae serotips 2 (celmi po, u3, b4, sz ii) - suspensija injekcijām - cūkas

Latvija - latviešu - Zāļu valsts aģentūra

teva b.v., netherlands - esomeprazols - zarnās šķīstošā tablete - 20 mg

Latvija - latviešu - Zāļu valsts aģentūra

teva b.v., netherlands - esomeprazols - pulveris injekciju/infūziju šķīduma pagatavošanai - 40 mg

Latvija - latviešu - Zāļu valsts aģentūra

unifarma, sia, latvia - esomeprazols - pulveris injekciju/infūziju šķīduma pagatavošanai - 40 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - c hepatīts, hronisks - pretvīrusu līdzekļi sistēmiskai lietošanai - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artrīts, reimatoīds - imūnsupresanti - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.